Jefferies Group LLC Bellus Health Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.56 - $7.99 $333,044 - $478,601
-59,900 Closed
0 $0
Q4 2021

Sep 21, 2023
BUY
$5.26 - $8.3 $315,074 - $497,170
59,900 New
59,900 $482,000
Q4 2021

Feb 14, 2022
BUY
$5.26 - $8.3 $315,074 - $497,170
59,900 New
59,900 $482,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email